Unique molecular characteristics of NAFLD-associated liver cancer accentuate beta-catenin/TNFRSF19-mediated immune evasion. Wong AM, Ding X, Wong AM, Xu M, et al. J Hepatol 2022;77:410-423.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wong AM, Ding X, Wong AM, Xu M, et al. Unique molecular characteristics of NAFLD-associated liver cancer accentuate beta-catenin/TNFRSF19-mediated immune evasion. J Hepatol 2022;77:410-423.
PMID: 35351523